http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019038783-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_440b3059c9bcd1d85fd383f9b2ae1b40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_065fe7c4146d471ac47823ff7c1d911f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4166 |
| filingDate | 2017-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f3ca4198b89a26db59923104dd05a66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a905d2a9883b2d85d1d2d4d8af53468c |
| publicationDate | 2019-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2019038783-A |
| titleOfInvention | Therapeutic agent for dry eye |
| abstract | An object of the present invention is to provide a pharmaceutical composition useful for treating dry eye. The present invention relates to pharmaceutical compositions useful for the treatment of dry eye. More particularly, the present invention relates to a pharmaceutical composition useful for the treatment of dry eye, which contains aldioxa (dihydroxyaluminum allantoate). The pharmaceutical composition of the present invention has a therapeutic effect on corneal epithelial disorders in dry eye. Therefore, the pharmaceutical composition of the present invention is useful as a therapeutic agent for dry eye treatment. [Selected figure] Figure 1 |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11759483-B2 |
| priorityDate | 2017-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.